BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33602087)

  • 21. Hippocampus-Based Dynamic Functional Connectivity Mapping in the Early Stages of Alzheimer's Disease.
    Wang J; Wang P; Jiang Y; Wang Z; Zhang H; Li H; Biswal BB
    J Alzheimers Dis; 2022; 85(4):1795-1806. PubMed ID: 34958033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
    van de Mortel LA; Thomas RM; van Wingen GA;
    J Alzheimers Dis; 2021; 83(2):705-720. PubMed ID: 34366336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort.
    Miller MI; Younes L; Ratnanather JT; Brown T; Trinh H; Lee DS; Tward D; Mahon PB; Mori S; Albert M;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S3-S10. PubMed ID: 25444602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.
    Devanand DP; Bansal R; Liu J; Hao X; Pradhaban G; Peterson BS
    Neuroimage; 2012 Apr; 60(3):1622-9. PubMed ID: 22289801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geodesic distance on a Grassmannian for monitoring the progression of Alzheimer's disease.
    Gui L; Tang X; Moura JMF
    Neuroimage; 2017 Feb; 146():1016-1024. PubMed ID: 27756616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.
    Henneman WJ; Sluimer JD; Barnes J; van der Flier WM; Sluimer IC; Fox NC; Scheltens P; Vrenken H; Barkhof F
    Neurology; 2009 Mar; 72(11):999-1007. PubMed ID: 19289740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
    Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
    Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI-based Alzheimer's disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer's disease.
    Liu W; Au LWC; Abrigo J; Luo Y; Wong A; Lam BYK; Fan X; Kwan PWL; Ma HW; Ng AYT; Chen S; Leung EYL; Ho CL; Wong SHM; Chu WC; Ko H; Lau AYL; Shi L; Mok VCT;
    Aging (Albany NY); 2021 May; 13(10):13496-13514. PubMed ID: 34091443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hierarchical Subcortical Sub-Regional Shape Network Analysis in Alzheimer's Disease.
    Li J; Gong Y; Tang X
    Neuroscience; 2017 Dec; 366():70-83. PubMed ID: 29037598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do multiple system atrophy and Parkinson's disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study.
    Wang N; Zhang L; Yang H; Luo X; Fan G
    Eur Radiol; 2019 Sep; 29(9):4948-4956. PubMed ID: 30796577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early amygdala and ERC atrophy linked to 3D reconstruction of rostral neurofibrillary tau tangle pathology in Alzheimer's disease.
    Stouffer KM; Chen C; Kulason S; Xu E; Witter MP; Ceritoglu C; Albert MS; Mori S; Troncoso J; Tward DJ; Miller MI;
    Neuroimage Clin; 2023; 38():103374. PubMed ID: 36934675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    Tai H; Hirano S; Sakurai T; Nakano Y; Ishikawa A; Kojima K; Li H; Shimada H; Kashiwado K; Mukai H; Horikoshi T; Sugiyama A; Uno T; Kuwabara S
    J Alzheimers Dis; 2020; 78(4):1639-1652. PubMed ID: 33185599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal Neuroimaging Hippocampal Markers for Diagnosing Alzheimer's Disease.
    Platero C; Lin L; Tobar MC
    Neuroinformatics; 2019 Jan; 17(1):43-61. PubMed ID: 29785624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.
    Eustache P; Nemmi F; Saint-Aubert L; Pariente J; Péran P
    J Alzheimers Dis; 2016; 50(4):1035-50. PubMed ID: 26836151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hippocampal formation alterations differently contribute to autobiographic memory deficits in mild cognitive impairment and Alzheimer's disease.
    Hirjak D; Wolf RC; Remmele B; Seidl U; Thomann AK; Kubera KM; Schröder J; Maier-Hein KH; Thomann PA
    Hippocampus; 2017 Jun; 27(6):702-715. PubMed ID: 28281317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline shape diffeomorphometry patterns of subcortical and ventricular structures in predicting conversion of mild cognitive impairment to Alzheimer's disease.
    Tang X; Holland D; Dale AM; Younes L; Miller MI
    J Alzheimers Dis; 2015; 44(2):599-611. PubMed ID: 25318546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.